Literature DB >> 9502447

Venezuelan hemorrhagic fever: clinical and epidemiological studies of 165 cases.

N de Manzione1, R A Salas, H Paredes, O Godoy, L Rojas, F Araoz, C F Fulhorst, T G Ksiazek, J N Mills, B A Ellis, C J Peters, R B Tesh.   

Abstract

Epidemiological and clinical data are presented on 165 cases of Venezuelan hemorrhagic fever (VHF), a newly emerging viral zoonosis caused by Guanarito virus (of the family Arenaviridae). The disease is endemic in a relatively circumscribed area of central Venezuela. Since its first recognition in 1989, the incidence of VHF has peaked each year between November and January, during the period of major agricultural activity in the region of endemicity. The majority of cases have involved male agricultural workers. Principal symptoms among the patients with VHF included fever, malaise, headache, arthralgia, sore throat, vomiting, abdominal pain, diarrhea, convulsions, and a variety of hemorrhagic manifestations. The majority of patients also had leukopenia and thrombocytopenia. The overall fatality rate among the 165 cases was 33.3%, despite hospitalization and vigorous supportive care.

Entities:  

Mesh:

Year:  1998        PMID: 9502447     DOI: 10.1086/516299

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  16 in total

1.  An antibody recognizing the apical domain of human transferrin receptor 1 efficiently inhibits the entry of all new world hemorrhagic Fever arenaviruses.

Authors:  Gustavo Helguera; Stephanie Jemielity; Jonathan Abraham; Sandra M Cordo; M Guadalupe Martinez; José A Rodríguez; Carlos Bregni; Jinyize J Wang; Michael Farzan; Manuel L Penichet; Nélida A Candurra; Hyeryun Choe
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

2.  Human and host species transferrin receptor 1 use by North American arenaviruses.

Authors:  Min Zong; Isabel Fofana; Hyeryun Choe
Journal:  J Virol       Date:  2014-06-11       Impact factor: 5.103

Review 3.  Targeting virulence mechanisms for the prevention and therapy of arenaviral hemorrhagic fever.

Authors:  Lisa McLay; Aftab Ansari; Yuying Liang; Hinh Ly
Journal:  Antiviral Res       Date:  2012-12-20       Impact factor: 5.970

4.  Use of recombinant adenovirus vectored consensus IFN-α to avert severe arenavirus infection.

Authors:  Brian B Gowen; Jane Ennis; Andrew Russell; Eric J Sefing; Min-Hui Wong; Jeffrey Turner
Journal:  PLoS One       Date:  2011-10-24       Impact factor: 3.240

Review 5.  Human hemorrhagic Fever causing arenaviruses: molecular mechanisms contributing to virus virulence and disease pathogenesis.

Authors:  Junjie Shao; Yuying Liang; Hinh Ly
Journal:  Pathogens       Date:  2015-05-21

Review 6.  Differential Immune Responses to New World and Old World Mammalian Arenaviruses.

Authors:  Hinh Ly
Journal:  Int J Mol Sci       Date:  2017-05-12       Impact factor: 5.923

7.  Combination of highly antigenic nucleoproteins to inaugurate a cross-reactive next generation vaccine candidate against Arenaviridae family.

Authors:  Kazi Faizul Azim; Tahera Lasker; Rahima Akter; Mantasha Mahmud Hia; Omar Faruk Bhuiyan; Mahmudul Hasan; Md Nazmul Hossain
Journal:  Heliyon       Date:  2021-05-19

Review 8.  Pathogenic mechanisms involved in the hematological alterations of arenavirus-induced hemorrhagic fevers.

Authors:  Mirta Schattner; Leonardo Rivadeneyra; Roberto G Pozner; Ricardo M Gómez
Journal:  Viruses       Date:  2013-01-21       Impact factor: 5.048

9.  Protein sequence database for pathogenic arenaviruses.

Authors:  Huynh-Hoa Bui; Jason Botten; Nicolas Fusseder; Valerie Pasquetto; Bianca Mothe; Michael J Buchmeier; Alessandro Sette
Journal:  Immunome Res       Date:  2007-02-08

10.  Lessons learnt from imported cases and onward transmission of Lassa fever in Europe support broader management of viral haemorrhagic fevers.

Authors:  Roger Hewson
Journal:  Euro Surveill       Date:  2017-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.